Serological fibroblast & ECM biomarkers of Prognosis, Diagnosis, Efficacy of intervention & Prediction
Time: 10:00 am
day: Conference Day 2 Morning
Details:
- Fibroblast activation is highly prognostic for liver, kidney and heart outcomes
- Weight dependent and weight independent de-activation of fibroblasts
- Tissue formation and tissue degradation: Matching Patient endotypes to treatments
